The suppressed expression of PTEN22 subsequently increases ERK1/2 activation and ultimately facilitates the formation of tubes in vivo and in vitro. Because of this, it was speculated that the HDAC10-PTEN22-ERK1/2 signaling pathway may contribute to tumor angiogenesis. The gene discussed is MAPK3; the disease is neoplasm.